April 26, 2018 / 5:08 AM / 3 months ago

BRIEF-Vistin Pharma Q1 EBITDA From Continuing Operations Up At NOK 6.3 Million

April 26 (Reuters) - VISTIN PHARMA ASA:

* REG-VISTIN PHARMA ASA : DELIVERS 22% REVENUE GROWTH IN FIRST QUARTER 2018

* Q1 REVENUE NOK 52.8 MILLION VERSUS NOK 43.4 MILLION YEAR AGO

* EBITDA FROM CONTINUING OPERATIONS CAME TO NOK 6.3 MILLION FOR Q1, COMPARED TO NOK 5.2 MILLION Q1 LAST YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below